Skip to content

Study of efficacy and safety of Ladycare® sanitary pad containing Potassium Alum

Study of Safety and efficacy of Ladycare ® sanitary pads contain potassium alum (Jahan Saderat Industrial Group production) in comparison of simple Ladycare pads on women residing in Iran

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015072617994N3
Enrollment
16
Registered
2016-08-04
Start date
2015-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erythema, Pruritis of genital area skin. Diaper [napkin] dermatitis, Pruritus vulvae

Interventions

Intervention 1: Intervention group will consume Ladycare® sanitary pad containing Potassium Alum during menstrual cycle. Intervention 2: Control group will consume simple Ladycare® sanitary pad durin
Intervention group will consume Ladycare® sanitary pad containing Potassium Alum during menstrual cycle
Control group will consume simple Ladycare® sanitary pad during menstrual cycle

Sponsors

Jahan Saderat Industrial Group
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1.Age between 18 and 50 2.History of regular menstrual cycles [21-35±) 3) days] over the last year 3.Good general health 4.Regular use of sanitary pads 5.Written Informed Consent to participate in the study according to the schedule. 6.Participant accepted to use only the assigned sanitary products for the study duration. Exclusion Criteria: 1.Use of any systemic medications for treating yeast, any medicated antipruritic or antifungal topical products to the genital area, and oral antibiotics within 2 weeks of baseline measurements 2.Pregnancy or planning to become pregnant during the study 3.Known allergy to sanitary pads, or to fragrances 4.Objective and/or subjective symptoms or positive culture results for bacterial vaginosis, yeast/Candida, or Trichomonasis 5.Study physician anticipated that continuance of the study would be inappropriate Withdrawal criteria: 1.shaving or using depilatories in the pubic region 2.applying personal or skin care products to the external genitalia and perineum 3.intercourse for 24 hours prior to scheduled clinical assessments 4.taking anti-inflammatory, antihistamine, or steroidal medications 5.participating in other clinical trials with similar products 6.severe side effects during the study 7.patient's non-compliance 8.using other sanitary pads during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Erythema in genital region skin. Timepoint: Before intervention and 7th and 14th day of each menstrual cycle. Method of measurement: objective scoring.;Perspiration in geital region. Timepoint: 7th day of each menstrual cycle. Method of measurement: Questionnaire.;Fungi colony (CFU/ml). Timepoint: Before intervention and 7th and 14th day of each menstrual cycle. Method of measurement: culture.

Secondary

MeasureTime frame
Total aerobic bacteria (CFU/ml). Timepoint: Before intervention and 7th and 14th day of each menstrual cycle. Method of measurement: culture.;PH. Timepoint: Before intervention and 7th and 14th day of each menstrual cycle. Method of measurement: pH meter.;Absorbency. Timepoint: 7th and 14th day of each menstrual cycle. Method of measurement: Questionnaire.;Dryness. Timepoint: 7th and 14th day of each menstrual cycle. Method of measurement: Questionnaire.;Softness. Timepoint: 7th and 14th day of each menstrual cycle. Method of measurement: Questionnaire.;Convenience. Timepoint: 7th and 14th day of each menstrual cycle. Method of measurement: Questionnaire.;Product satisfaction. Timepoint: 7th and 14th day of each menstrual cycle. Method of measurement: Questionnaire.;Fissuring. Timepoint: Before intervention and 7th and 14th day of each menstrual cycle. Method of measurement: Objective scoring.;Edema. Timepoint: Before intervention and 7th and 14th day of each menstrual cycle. Method of measurement: Objective scoring.;Papule. Timepoint: Before intervention and 7th and 14th day of each menstrual cycle. Method of measurement: Objective scoring.;Itching. Timepoint: Before intervention and 7th and 14th day of each menstrual cycle. Method of measurement: Questionnaire.;Burning. Timepoint: Before intervention and 7th and 14th day of each menstrual cycle. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Firooz

Center for Research & Training in Skin Diseases & Leprosy

firozali@tums.ac.ir+98 21 8897 8190

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026